Skip to product information
1 of 1

Molecular Neurobiology for the Clinician

Regular price £52.00
Sale price £52.00 Regular price £52.00
Sale Sold out
This book discusses discoveries that have the potential to revolutionize your clinical approach. Clinicians will learn about the effects on psychiatry of advances in the molecular basis of neuronal...
Read More
  • Format:
  • 21 June 2003
View Product Details

In this authoritative volume you'll find today's most important molecular neurobiological advances and their relevance to clinicians treating patients with mental illness. Molecular Neurobiology for the Clinician, Review of Psychiatry, Volume 22, will update you on the latest findings—and their impact on psychiatry.

You'll learn about

• Discoveries with the potential to revolutionize your clinical approach by changing the ways in which you diagnose and treat patients
• The effects on psychiatry of advances in the molecular basis of neuronal network function, particularly in relation to abnormalities in cognitive and emotional regulation, and the identification of novel molecular targets for drug development
• How to apply these discoveries to diagnosing and treating major psychiatric disorders, including childhood- and adolescent-onset disorders, schizophrenia, drug addiction, and severe mood and anxiety disorders

Molecular Neurobiology for the Clinician is an outstanding compilation of the best research by top names in the field. Psychiatrists, psychologists, psychiatric residents, and graduate students in neuroscience, psychiatry, and psychology will gain knowledge, understanding, and techniques for better diagnosis and treatment.

files/i.png Icon
Price: £52.00
Pages: 272
Publisher: American Psychiatric Association Publishing
Imprint: American Psychiatric Association Publishing
Publication Date: 21 June 2003
ISBN: 9781585621132
Format: Paperback
BISACs:

MEDICAL / Psychiatry / General

REVIEWS Icon

This multiauthor text explores the current state of knowledge of molecular abnormalities in psychiatric disorders. The book does an outstanding job of illustrating the interface between basic science and clinical psychiatry. . . . The authors artfully integrate what is known about genetics and neurochemistry with diagnosis and treatment of several psychiatric disorders.


— Michael Garvey, M.D.

Dennis S. Charney, M.D., is Chief of the Mood and Anxiety Disorders Program, and Chief of the Experimental Therapeutics and Pathophysiology Branch, at the National Institute of Mental Health in Bethesda, Maryland.

Contributors
Introduction to the Review of Psychiatry Series
Preface
Chapter 1. Molecular neurobiology of childhood- and adolescent-onset psychiatric disorders
Chapter 2. Molecular genetics: a role in diagnosis and treatment of psychiatric disorders?
Chapter 3. Molecular neurobiology and schizophrenia: implications for etiology and treatment
Chapter 4. Molecular mechanisms of drug addiction
Chapter 5. Cellular neurobiology of severe mood and anxiety disorders: implications for development of novel therapeutics
Index